GlassScriptPhysician profile
Amy E Flammer
NPI 1457796302
$1,744.78
in general payments reported to CMS, 2019-2025
15 companies · $48.70 in 2025
The $48.70 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $127 · 2021: $32.03 · 2022: $194 · 2024: $1,000 · 2025: $48.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,000 · Food and Beverage: $48.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,000.00 |
| Food and Beverage | $48.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $1,000.00 | 2024 | |
| Abbvie INC. | $169.92 | 2019-2020 | |
| Pfizer INC. | $113.21 | 2019-2022 | |
| Amgen INC. | $97.27 | 2019 | |
| Aspira Women'S Health INC | $89.28 | 2022 | |
| Intuitive Surgical, INC. | $60.01 | 2020 | |
| Myovant Sciences INC. | $45.42 | 2022 | |
| Ethicon US, LLC | $29.57 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.74 | 2020 | |
| Merck Sharp & Dohme LLC | $25.90 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $25.30 | 2025 | Exparel |
| Hologic Sales and Service, LLC | $23.40 | 2025 | Myosure Tissue Removal Device, Novasure |
| Therapeuticsmd, INC. | $14.11 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.41 | 2019 | |
| Roche Diagnostics Corporation | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Flammer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.